Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions: A Review of 198 Submissions Between 2000 and 2008

Author： >   Garnett Christine E.   Gobburu Jogarao V.S.   Bhattaram Venkatesh A.   Brar Satjit   Earp Justin C.   Jadhav Pravin R.   Krudys Kevin   Lesko Lawrence J.   Li Fang   Liu Jiang   Madabushi Rajnikanth   Marathe Anshu   Mehrotra Nitin   Tornoe Christoffer   Wang Yaning   Zhu Hao  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.50, Iss.10, 2011-10, pp. : 627-635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Drug-Induced QT Interval Prolongation: Implications for Drug Approval and Labelling

By Malik M.   Camm A.J.  

Drug Safety, Vol. 24, Iss. 5, 2001-01 ,pp. : 323-351

Adis International

Access to resources Recommend Favorite

Utilisation of Foreign Clinical Data in Japanese New Drug Approval Review: On What Basis Did the Regulatory Agency Accept Them?

By Shunsuke Ono  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 3, 2004-01 ,pp. : 159-165

Adis International

Access to resources Recommend Favorite

Common drug review aids drug coverage decisions

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 510, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The US Government Accountability Office is to review a drug approval process used by the FDA

By  

Inpharma, Vol. 1, Iss. 1633, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Drug Approval Process – In United States of America, European Union and India: A Review

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 1, 2014-04 ,pp. : 13-22

Bentham Science Publishers

Access to resources Recommend Favorite